心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

高血压基层合理用药指南

2021-01-04 中华医学会 中华全科医师杂志. 2021,20(01)

高血压

2021年1月中华医学会发布高血压基层合理用药指南。

中文标题：

高血压基层合理用药指南

发布机构：

中华医学会

发布日期：

2021-01-04

简要介绍：

2021年1月中华医学会发布高血压基层合理用药指南。

相关资料下载：
[AttachmentFileName(sort=1, fileName=高血压基层合理用药指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4a60e1c002169229, title=高血压基层合理用药指南, enTitle=, guiderFrom=中华全科医师杂志. 2021,20(01), authorId=0, author=, summary=2021年1月中华医学会发布高血压基层合理用药指南。, cover=https://img.medsci.cn/2021831/1630425206008_2020535.jpg, journalId=0, articlesId=null, associationId=359, associationName=中华医学会, associationIntro=中华医学会是中国医学科学技术工作者自愿组成并依法登记成立的学术性、公益性、非营利性法人社团，是党和国家联系医学科技工作者的桥梁和纽带，是发展中国医学科学技术事业的重要社会力量。 中华医学会(Chinese Medical Association)成立于1915年。现有83个专科分会，50万名会员，下设部门16个，法人实体机构3个，另与解放军军事医学科学院合办医学图书馆1个。 中华医学会的主要业务包括：开展医学学术交流；编辑出版123种医学、科普等各类期刊及100余种音像出版物；开展继续医学教育；开展国际间学术交流；开展医学科技项目的评价、评审和医学科学技术决策论证；评选和奖励优秀医学科技成果（包括学术论文和科普作品等）；开展专科医师的培训和考核；发现、推荐和培养优秀医学科技人才；宣传、奖励医德高尚、业务精良的医务人员；承担政府委托职能及承办委托任务；设立临床研究专项资金，提高临床科研水平；组织医疗事故技术鉴定和预防接种异常反应技术鉴定工作；推动医学科研成果的转化和应用；向党和政府反映医学科技工作者的意见和要求。, copyright=0, guiderPublishedTime=Mon Jan 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>2021年1月中华医学会发布高血压基层合理用药指南。</p>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5605, appHits=1549, showAppHits=0, pcHits=1135, showPcHits=4048, likes=5, shares=141, comments=81, approvalStatus=1, publishedTime=Tue Aug 31 23:53:41 CST 2021, publishedTimeString=2021-01-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 31 23:53:31 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:39:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=高血压基层合理用药指南.pdf)])
高血压基层合理用药指南.pdf
下载请点击：
评论区 (67)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241813, encodeId=7f9712418132b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7c8278072, createdName=ms5000000256203344, createdTime=Mon Aug 29 11:40:49 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228994, encodeId=61cf1228994ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34446512602, createdName=ms6000000755974223, createdTime=Mon Jun 27 17:47:58 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226828, encodeId=6766122682869, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Thu Jun 16 15:42:14 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214841, encodeId=206b121484190, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:26:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205767, encodeId=a7f61205e673d, content=这是个好地方！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7c3759448, createdName=135e0faem06暂无昵称, createdTime=Fri Mar 25 08:39:49 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-08-29 ms5000000256203344

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241813, encodeId=7f9712418132b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7c8278072, createdName=ms5000000256203344, createdTime=Mon Aug 29 11:40:49 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228994, encodeId=61cf1228994ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34446512602, createdName=ms6000000755974223, createdTime=Mon Jun 27 17:47:58 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226828, encodeId=6766122682869, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Thu Jun 16 15:42:14 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214841, encodeId=206b121484190, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:26:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205767, encodeId=a7f61205e673d, content=这是个好地方！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7c3759448, createdName=135e0faem06暂无昵称, createdTime=Fri Mar 25 08:39:49 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-06-27 ms6000000755974223

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241813, encodeId=7f9712418132b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7c8278072, createdName=ms5000000256203344, createdTime=Mon Aug 29 11:40:49 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228994, encodeId=61cf1228994ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34446512602, createdName=ms6000000755974223, createdTime=Mon Jun 27 17:47:58 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226828, encodeId=6766122682869, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Thu Jun 16 15:42:14 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214841, encodeId=206b121484190, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:26:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205767, encodeId=a7f61205e673d, content=这是个好地方！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7c3759448, createdName=135e0faem06暂无昵称, createdTime=Fri Mar 25 08:39:49 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-06-16 ms1000001687352890

    感谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241813, encodeId=7f9712418132b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7c8278072, createdName=ms5000000256203344, createdTime=Mon Aug 29 11:40:49 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228994, encodeId=61cf1228994ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34446512602, createdName=ms6000000755974223, createdTime=Mon Jun 27 17:47:58 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226828, encodeId=6766122682869, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Thu Jun 16 15:42:14 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214841, encodeId=206b121484190, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:26:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205767, encodeId=a7f61205e673d, content=这是个好地方！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7c3759448, createdName=135e0faem06暂无昵称, createdTime=Fri Mar 25 08:39:49 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241813, encodeId=7f9712418132b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a7c8278072, createdName=ms5000000256203344, createdTime=Mon Aug 29 11:40:49 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228994, encodeId=61cf1228994ba, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34446512602, createdName=ms6000000755974223, createdTime=Mon Jun 27 17:47:58 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226828, encodeId=6766122682869, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Thu Jun 16 15:42:14 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214841, encodeId=206b121484190, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:26:45 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205767, encodeId=a7f61205e673d, content=这是个好地方！谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df7c3759448, createdName=135e0faem06暂无昵称, createdTime=Fri Mar 25 08:39:49 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-25 135e0faem06暂无昵称

    这是个好地方！谢谢

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

世界卫生组织（WHO）：2021年成人高血压药物治疗指南

世界卫生组织(WHO,The World Health Organization) · 2021-08-26

成年人精神压力相关高血压诊疗专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2021-08-10

2021 ESH意见书：高血压和射血分数保留的心力衰竭

欧洲高血压学会(ESH,European Society of Hypertension) · 2021-05-30

2021 AHA科学声明：体育锻炼作为高血压或胆固醇升高一线治疗的重要组成

美国心脏协会(AHA,American Heart Association) · 2021-06-02

2021 昆士兰临床指南：高血压和妊娠

昆士兰卫生组织(QLD,Queensland Health) · 2021-05-01

中国高血压患者心率管理多学科专家共识（2021年版）

暂未更新 · 2021-04-20

拓展阅读

2009ESH 欧洲高血压指南重新评估

欧洲高血压学会(ESH,European Society of Hypertension) · 2009-11-01

2010 台湾高血压管理指南（英文版）

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2010-01-01

2010年中国肺高血压诊治指南

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

2010高血压患者胆固醇管理临床指导建议

中国心血管相关专家小组（统称） · 2010-02-01

2009年基层版《中国高血压防治指南》

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2010-02-10

2010 中国急诊高血压管理专家共识

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2010-03-19